Detalhe da pesquisa
1.
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1.
N Engl J Med
; 384(13): 1216-1226, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33789010
2.
American Board of Internal Medicine Nephrology Procedure Requirements for Initial Certification: Time for a Change and Pursuing Consensus in the Nephrology Community.
Am J Kidney Dis
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38640993
3.
Natural history of urine and plasma oxalate in children with primary hyperoxaluria type 1.
Pediatr Nephrol
; 39(1): 141-148, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37458799
4.
Outpatient Antibiotic Use is Not Associated with an Increased Risk of First-Time Symptomatic Kidney Stones.
J Am Soc Nephrol
; 34(8): 1399-1408, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37184480
5.
Estimating glomerular filtration rate with new equations: can one size ever fit all?
Crit Rev Clin Lab Sci
; 60(7): 549-559, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37259709
6.
PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2.
Kidney Int
; 103(1): 207-217, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36007597
7.
Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis.
Kidney Int
; 103(3): 565-579, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36442540
8.
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification.
Kidney Int
; 104(6): 1092-1102, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37795587
9.
NMRpQuant: an automated software for large scale urinary total protein quantification by one-dimensional 1H NMR profiles.
Bioinformatics
; 38(18): 4437-4439, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35861573
10.
Characterization of Stone Events in Patients With Type 3 Primary Hyperoxaluria.
J Urol
; 209(6): 1141-1150, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36888927
11.
Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.
Am J Kidney Dis
; 81(2): 145-155.e1, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35843439
12.
Impact of race-independent equations on estimating glomerular filtration rate for the assessment of kidney dysfunction in liver disease.
BMC Nephrol
; 24(1): 83, 2023 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37003973
13.
Nuclear Magnetic Resonance Metabolomic Profiling and Urine Chemistries in Incident Kidney Stone Formers Compared with Controls.
J Am Soc Nephrol
; 33(11): 2071-2086, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36316097
14.
Posttransplant recurrence of calcium oxalate crystals in patients with primary hyperoxaluria: Incidence, risk factors, and effect on renal allograft function.
Am J Transplant
; 22(1): 85-95, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34174139
15.
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
N Engl J Med
; 381(1): 36-46, 2019 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31269364
16.
Clinical Impact of the Refit CKD-EPI 2021 Creatinine-Based eGFR Equation.
Clin Chem
; 68(4): 534-539, 2022 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35038721
17.
New therapeutics for primary hyperoxaluria type 1.
Curr Opin Nephrol Hypertens
; 31(4): 344-350, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35266883
18.
Estimated GFR Slope Across CKD Stages in Primary Hyperoxaluria Type 1.
Am J Kidney Dis
; 80(3): 373-382, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35306035
19.
Primary Hyperoxaluria Type 3 Can Also Result in Kidney Failure: A Case Report.
Am J Kidney Dis
; 79(1): 125-128, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34245816
20.
Nephrotoxin Exposure in the 3 Years following Hospital Discharge Predicts Development or Worsening of Chronic Kidney Disease among Acute Kidney Injury Survivors.
Am J Nephrol
; 53(4): 273-281, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35294951